Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 16 (Search time: 0.03 seconds).
Item hits:
Issue DateTitleAuthor(s)
11-Jul-2019Daratumumab displays in vitro and in vivo anti-tumor activity in models of B cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimensVidal Crespo, Anna; Matas Céspedes, Alba; Rodríguez, Vanina; Rossi, Cédric; Valero, Juan G.; Serrat, Neus; Sanjuan Pla, Alejandra; Menéndez Buján, Pablo; Roué, Gaël; López Guillermo, Armando; Giné Soca, Eva; Campo Güerri, Elias; Colomer Pujol, Dolors; Bezombes, Christine; Lammerts van Bueren, J.; Chiu, Christopher; Doshi, Parul; Pérez Galán, Patricia
1-Nov-2004Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasmsFernàndez Pascual, Verònica; Jares Gerboles, Pedro; Beà Bobet, Sílvia M.; Salaverria Frigola, Itziar; Guinó, Elisabet; Sanjosé Llongueras, Silvia de; Colomer Pujol, Dolors; Ott, German; Montserrat Costa, Emilio; Campo Güerri, Elias
1-Nov-2019Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.Silkenstedt, Elisabeth; Arenas, Fabian; Colom-Sanmartí, Berta; Xargay i Torrent, Sílvia; Higashi, Morihiro; Giró, Ariadna; Rodríguez, Vanina; Fuentes, Patricia; Aulitzky, Walter E.; Kuip, Heiko van der; Beà Bobet, Sílvia M.; Toribio, María L.; Campo Güerri, Elias; López-Guerra, Mónica; Colomer Pujol, Dolors
25-Jul-2014Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphomaRosich, Laia; Montraveta, Arnau; Xargay i Torrent, Sílvia; López-Guerra, Mónica; Roldán, Jocabed; Aymerich Gregorio, Marta; Salaverria Frigola, Itziar; Beà Bobet, Sílvia M.; Campo Güerri, Elias; Pérez Galán, Patricia; Roué, Gaël; Colomer Pujol, Dolors
15-Oct-2019Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cellsLópez-Guerra, Mónica; Xargay i Torrent, Sílvia; Fuentes, Patricia; Roldán, Jocabed; González Farré, Blanca; Rosich, Laia; Silkenstedt, Elisabeth; García León, María J.; Lee-Vergés, Eriong; Giménez Carabaza, Neus; Giró, Ariadna; Aymerich Gregorio, Marta; Villamor i Casas, Neus; Delgado, Julio (Delgado González); López Guillermo, Armando; Puente, Xose S.; Campo Güerri, Elias; Toribio, María L.; Colomer Pujol, Dolors
8-Jun-2015The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemiaXargay i Torrent, Sílvia; López-Guerra, Mónica; Rosich, Laia; Montraveta, Arnau; Roldán, Jocabed; Rodríguez, Vanina; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Lagisetti, Chandraiah; Webb, Thomas R.; López-Otin, Carlos; Campo Güerri, Elias; Colomer Pujol, Dolors
Mar-2019Mutations in RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaGiménez Carabaza, Neus; Martínez Trillos, Alejandra; Montraveta, Arnau; López-Guerra, Mónica; Rosich, Laia; Nadeu Prat, Ferran; Valero, Juan G.; Aymerich Gregorio, Marta; Magnano, Laura; Rozman, María; Matutes, Estella; Delgado, Julio (Delgado González); Baumann, Tycho; Gine, Eva; González, Marcos; Alcoceba, Miguel; Terol, Maria José; Navarro, Blanca; Colado, Enrique; Payer, Ángel R.; Puente, Xose S.; López-Otin, Carlos; López Guillermo, Armando; Campo Güerri, Elias; Colomer Pujol, Dolors; Villamor i Casas, Neus
31-Aug-2018Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neosplasmsAlbero, Robert; Enjuanes, Anna; Demajo, Santiago; Castellano, Giancarlo; Pinyol, Magda; García, Noelia; Capdevila, Cristina; Clot Razquin, Guillem; Suárez-Cisneros, Helena; Shimada, Mariko; Karube, Kennosuke; López-Guerra, Mónica; Colomer Pujol, Dolors; Beà Bobet, Sílvia M.; Martín-Subero, José Ignacio; Campo Güerri, Elias; Jares Gerboles, Pedro
10-Aug-2023BCL3-rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseasesCarbó-Meix, Anna; Guijarro, Francesca; Wang, Luojuon; Grau, Marta; Royo, Romina; Frigola, Gerard; Playà-Albinyana, Heribert; Bühler, Marco M.; Clot Razquin, Guillem; Duran-Ferrer, Martí; Lu, Junyan; Granada, Isabel; Baptista, Maria-Joao; Navarro, José-Tomás; Espinet Solà, Blanca; Puiggròs Metje, Anna Maria; Tapia, Gustavo; Bandiera, Laura; De Canal, Gabriella; Bonoldi, Emanuela; Climent, Fina; Ribera Cortada, Inmaculada; Fernández-Caballero, Mariana; De la Banda, Esmeralda; Do Nascimento, Janilson; Pineda, Alberto; Vela, Dolors; Rozman, María; Aymerich Gregorio, Marta; Syrykh, Charlotte; Brousset, Pierre; Perera, Miguel; Yáñez, Lucrecia; Ortin, Jesús Xavier; Tuset, Esperanza; Zenz, Thorsten; Cook, James R.; Swerdlow, Steven H.; Martín-Subero, José Ignacio; Colomer Pujol, Dolors; Matutes, Estella; Beà Bobet, Sílvia M.; Costa, Dolors; Nadeu Prat, Ferran; Campo Güerri, Elias
19-Dec-2015CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemiaMontraveta, Arnau; Lee-Vergés, Eriong; Roldán, Jocabed; Jiménez, Laura; Cabezas, Sandra; Clot Razquin, Guillem; Pinyol, Magda; Xargay i Torrent, Sílvia; Rosich, Laia; Arimany Nardi, Cristina; Aymerich Gregorio, Marta; Villamor i Casas, Neus; López Guillermo, Armando; Pérez Galán, Patricia; Roué, Gaël; Pastor Anglada, Marçal; Campo Güerri, Elias; López-Guerra, Mónica; Colomer Pujol, Dolors